Fmr LLC Ocular Therapeutix, Inc Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Fmr LLC holds 6,034 shares of OCUL stock, worth $54,607. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,034

Previous 69,092 91.27%

Holding current value

$54,607

Previous $628,000 93.47%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$4.2 - $8.69 $264,843 - $547,974	-63,058 Reduced 91.27%	6,034 $41,000
Q1 2024 May 13, 2024	SELL	$3.85 - $10.93 $107 - $306	-28 Reduced 0.04%	69,092 $628,000
Q4 2023 Feb 13, 2024	BUY	$2.08 - $4.52 $707 - $1,536	340 Added 0.49%	69,120 $308,000
Q3 2023 Nov 13, 2023	BUY	$3.14 - $5.04 $197,170 - $316,476	62,793 Added 1048.82%	68,780 $215,000
Q2 2023 Aug 11, 2023	BUY	$4.6 - $7.64 $5,685 - $9,443	1,236 Added 26.02%	5,987 $30,000
Q1 2023 May 11, 2023	BUY	$2.79 - $6.27 $6,068 - $13,637	2,175 Added 84.43%	4,751 $25,000
Q4 2022 Feb 13, 2023	SELL	$2.61 - $4.41 $6,417 - $10,844	-2,459 Reduced 48.84%	2,576 $7,000
Q3 2022 Nov 10, 2022	BUY	$4.09 - $6.5 $6,650 - $10,569	1,626 Added 47.7%	5,035 $21,000
Q2 2022 Aug 12, 2022	BUY	$3.01 - $5.22 $3,825 - $6,634	1,271 Added 59.45%	3,409 $14,000
Q1 2022 May 13, 2022	BUY	$4.83 - $7.35 $10,326 - $15,714	2,138 New	2,138 $11,000
Q4 2021 Feb 14, 2022	SELL	$6.16 - $12.07 $6.99 Million - $13.7 Million	-1,135,345 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$9.7 - $14.34 $616,842 - $911,909	-63,592 Reduced 5.3%	1,135,345 $11.4 Million
Q2 2021 Aug 13, 2021	BUY	$13.43 - $19.16 $16.1 Million - $23 Million	1,198,937 New	1,198,937 $17 Million

Others Institutions Holding OCUL

# of Institutions

151

Shares Held

136M

Call Options Held

86.4K

Put Options Held

263K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $697M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account